Paul Tudor Jones's SMMT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 384,988 shares of Summit Therapeutics Inc. (SMMT) worth $7.3 M, representing 0.01% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 6 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in SMMT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 347,241 shares. Largest reduction occurred in Q1 2026, reducing 38,096 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Summit Therapeutics (SMMT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Summit Therapeutics (SMMT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -38,096 | Reduce 9.00% | 384,988 | $18.96 |
| Q4 2025 | +75,843 | Add 21.84% | 423,084 | $17.49 |
| Q3 2025 | +347,241 | New Buy | 347,241 | $20.66 |
| Q3 2023 | -32,103 | Sold Out | 0 | $0.00 |
| Q2 2023 | +16,988 | Add 112.39% | 32,103 | $2.51 |
| Q1 2023 | +15,115 | New Buy | 15,115 | $0.00 |
Paul Tudor Jones's Summit Therapeutics Investment FAQs
Paul Tudor Jones first purchased Summit Therapeutics Inc. (SMMT) in Q1 2023, acquiring 15,115 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Summit Therapeutics Inc. (SMMT) for 6 quarters since Q1 2023.
Paul Tudor Jones's largest addition to Summit Therapeutics Inc. (SMMT) was in Q3 2025, adding 347,241 shares worth $7.17 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 384,988 shares of Summit Therapeutics Inc. (SMMT), valued at approximately $7.3 M.
As of the Q1 2026 filing, Summit Therapeutics Inc. (SMMT) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Summit Therapeutics Inc. (SMMT) was 423,084 shares, as reported at the end of Q4 2025.